Biocon Q1 net profit falls 95% to Rs 31 crore
🕒 1 min read
Biocon’s consolidated net profit plummeted by 95% to Rs 31 crore in the June quarter, with total revenue declining to Rs 4,022 crore. Despite this, operating revenue increased by 15% YoY, driven by Biosimilars and CRDMO gains. A recent QIP has strengthened the balance sheet, enabling increased ownership in Biocon Biologics and positioning the company for long-term value creation.
Continue Reading
- India’s data centre sector draws $15 billion since 2020, set to add $20-$25 billion by 2030: Report
-
Pakistan’s Share In ICC Revenue And Why India Boycott Is A USD 144 Million Disaster For Mohsin Naqvi And Co.
- IRCTC Got Over 6,000 Complaints On Poor Food Quality In 2024-25: Minister
- Three months of Hormuz chaos: Oil prices jump 3% amid US-Iran standoff
-
“Great Man”: Trump Praises PM Modi’s Meeting With US Envoy Sergio Gor
-
Smriti Mandhana’s Fiance Palash Muchhal Gets SM18 Tattoo, Internet In Overdrive
- Trump Asked Which World Leader He Admires Most, He Picks PM Modi, Xi Jinping
- Corporate India may avoid the worst of the Middle East crisis if US-Iran truce holds: Crisil
- 82-Year-Old Man Selling Snacks In Borivali Goes Viral For His Inspiring Work Ethic
- Sri Lanka vs Afghanistan Live Streaming, Asia Cup 2025 Live Telecast: When And Where To Watch